MARATTO

article · Scientific Reports

Analysis of capivasertib via ion-pairing with erythrocin B as a spectrofluorometric probe

2026Open accessMinia University

Abstract

A novel, eco-friendly spectrofluorimetric method has been developed for the sensitive determination of capivasertib, based on resonance Rayleigh scattering enhancement. Unlike previously reported methods, this approach utilizes erythrosine B as a safer ion-pairing reagent in an acidic aqueous medium, eliminating the need for organic solvents or complex extraction steps. The interaction between capivasertib and erythrosine B leads to a stable ion-pair complex, producing a strong Rayleigh scattering signal measurable at λex530/λem550 nm. The method demonstrated excellent linearity over the range of 20-2000 ng mL⁻¹, with a detection limit of 5.61 ng mL⁻¹ and a quantification limit of 17 ng mL⁻¹. All analytical parameters were optimized and validated according to ICH guidelines. To holistically substantiate sustainability, the method's environmental and practical profiles were appraised using all contemporary greenness/whiteness/applicability metrics employed in this work: Analytical Eco-Scale (ESA), NEMI pictogram, GAPI, AGREE, and AGREE-prep for sample-preparation greenness; the White Analytical Chemistry RGB12 model (whiteness); and the Blue Applicability Grade Index (BAGI) (blueness/applicability). This work introduces a greener, simpler, and more accessible alternative for capivasertib analysis, with potential applications in pharmaceutical quality control and routine laboratory testing.

Research topics

  • Analytical Methods in Pharmaceuticals
  • Protein Interaction Studies and Fluorescence Analysis
  • Molecular Sensors and Ion Detection

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

DOI: 10.1038/s41598-026-49688-5

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.